首页> 外文期刊>Cell Reports >Kcnn4 Is a Regulator of Macrophage Multinucleation in Bone Homeostasis and Inflammatory Disease
【24h】

Kcnn4 Is a Regulator of Macrophage Multinucleation in Bone Homeostasis and Inflammatory Disease

机译:Kcnn4是巨噬细胞多稳态在骨稳态和炎症性疾病中的调节因子。

获取原文
           

摘要

Macrophages can fuse to form osteoclasts in bone or multinucleate giant cells (MGCs) as part of the immune response. We use a systems genetics approach in rat macrophages to unravel their genetic determinants of multinucleation and investigate their role in both bone homeostasis and inflammatory disease. We identify a trans-regulated gene network associated with macrophage multinucleation and Kcnn4 as being the most significantly trans-regulated gene in the network and induced at the onset of fusion. Kcnn4 is required for osteoclast and MGC formation in rodents and humans. Genetic deletion of Kcnn4 reduces macrophage multinucleation through modulation of Ca^2^+ signaling, increases bone mass, and improves clinical outcome in arthritis. Pharmacological blockade of Kcnn4 reduces experimental glomerulonephritis. Our data implicate Kcnn4 in macrophage multinucleation, identifying it as a potential therapeutic target for inhibition of bone resorption and chronic inflammation.
机译:作为免疫反应的一部分,巨噬细胞可在骨骼或多核巨细胞(MGC)中融合形成破骨细胞。我们在大鼠巨噬细胞中使用系统遗传学方法来揭示其多核化的遗传决定因素,并研究其在骨稳态和炎症性疾病中的作用。我们确定与巨噬细胞多核化和Kcnn4相关联的反式调控的基因网络是网络中最显着的反式调控基因,并在融合开始时被诱导。 Kcnn4是啮齿动物和人类中破骨细胞和MGC形成所必需的。 Kcnn4的遗传缺失通过调节Ca ^ 2 ^ +信号传导减少巨噬细胞多核化,增加骨量,并改善关节炎的临床结局。 Kcnn4的药理阻断作用可减少实验性肾小球肾炎。我们的数据表明Kcnn4参与巨噬细胞多核化,并将其确定为抑制骨吸收和慢性炎症的潜在治疗靶标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号